Gynecologic Oncology Update
34 episodes
S24 Ep 19Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Prof Nicoletta Colombo and Dr Kathleen N Moore discuss the selection and sequencing of therapy for patients with ovarian cancer and summarize major advances in the treatment landscape over the past year.CME information and select publications here.
S24 Ep 18Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting
Dr Ritu Salani from the David Geffen School of Medicine at UCLA in Los Angeles, California, reviews datasets from ESMO Congress 2025 relevant to the care of patients with gynecologic cancers.CME information and select publications here.
S24 Ep 17Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore
Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on available and novel treatment strategies with antibody-drug conjugates for ovarian cancer.CME information and select publications here.
S24 Ep 16Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Dr Gottfried E Konecny from the University of California, Los Angeles, summarizes the treatment landscape and reviews relevant clinical datasets for patients with ovarian cancer. CME information and select publications here.
S24 Ep 15Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases
Dr Kathleen N Moore from OU Health Stephenson Cancer Center in Oklahoma City, Oklahoma, and Dr Matthew A Powell from the Washington University School of Medicine in St Louis, Missouri, discuss recent updates on available and novel treatment strategies for endometrial cancer. CME information and select publications here.
S24 Ep 14Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm
Dr Shannon Westin from the University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for ovarian and endometrial cancer. CME information and select publications here.
S24 Ep 13Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances
Prof Susana Banerjee from The Institute of Cancer Research in London and Dr Ursula Matulonis from Dana-Farber Cancer Institute in Boston discuss important efficacy and safety data from the past year related to the management of ovarian, endometrial and cervical cancers.CME information and select publications here.
S24 Ep 12Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches
Ms Jennifer Filipi from the Massachusetts General Hospital Cancer Center in Boston discusses nursing considerations for the treatment of ovarian cancer. NCPD information and select publications here.
S24 Ep 11Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
Drs Joyce F Liu, David M O’Malley, Ritu Salani, Alessandro D Santin and moderator Dr Shannon N Westin present data informing treatment decision-making for patients with advanced ovarian and endometrial cancers at the 2025 ASCO annual meeting. CME information and select publications here.
S24 Ep 10For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress
Dr David O’Malley and Dr Shannon Westin summarize the clinical treatment landscape for ovarian cancers, supported by clinical perspectives and management strategies from nurse practitioners Ms Courtney Arn and Ms Jennifer Filipi. NCPD information and select publications here.
S24 Ep 9For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress
Dr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.
S24 Ep 8Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit
Clinical investigators discuss available data guiding the management of gynecologic cancers. CME information and select publications here.
S24 Ep 7Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
Dr Kathleen Moore, Dr Ritu Salani, Dr Shannon Westin and moderator Dr Angeles Alvarez Secord share their perspectives and summarize recently presented data from the SGO 2025 annual meeting guiding the management of ovarian cancer. CME information and select publications here.
S24 Ep 6HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
Drs Kathleen N Moore and Alessandro D Santin and moderator Dr David M O’Malley summarize and share their perspectives on data guiding the management of HER2-positive gynecologic cancers that were presented at the Society of Gynecologic Oncology 2025 annual meeting. CME information and select publications here.
S24 Ep 5Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers
Dr Kathleen N Moore shares her perspectives on the evolving therapeutic landscape for patients with gynecologic cancers.
S24 Ep 4Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers.
S24 Ep 3Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers.
S24 Ep 2Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
Dr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer.
S24 Ep 1Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer.
S23 Ep 11Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.
S23 Ep 10Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
Dr Richard Penson from Massachusetts General Hospital in Boston, Massachusetts and Dr Krishnansu Tewari from the University of California, Irvine, discuss updated data from the 2023 ESMO Congress on optimal management approaches for gynecologic cancers.
S23 Ep 9Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
Dr David M O’Malley from the Ohio State University and the James Cancer Center in Columbus, Ohio, discusses optimizing the management of ovarian cancer.
S23 Ep 8Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
Dr Kathleen Moore from OU Health Stephenson Cancer Center in Oklahoma City discusses treatment decision-making for real-world cases and approved and investigational treatment strategies for the management of ovarian cancer.
S23 Ep 7Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer
Dr Debra L Richardson from OU Health Stephenson Cancer Center in Oklahoma City discusses novel agents and strategies for ovarian cancer.
S23 Ep 6Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Featuring a discussion on recent updates in the management of gynecologic cancers from the ASCO 2023 Annual Meeting with Dr Floor Backes, moderated by Dr Neil Love.
S23 Ep 5Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
Dr David O’Malley from The James Cancer Center in Columbus, Ohio, discusses recent advances in the management of ovarian cancer, including presentations from ASCO 2023.
S23 Ep 4The Implications of New Research Findings for the Management of Endometrial Cancer
Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell, moderated by Dr Neil Love.
S23 Ep 3Recent Advances and Future Directions in Gynecologic Cancers — With Dr Michael Birrer and Ursula Matulonis (Proceedings from a Symposium in Partnership with NCOA and SCOS)
Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.
S23 Ep 2Oncology Today with Dr Neil Love: Management of Desmoid Tumors
Featuring a discussion on the management of desmoid tumors with Dr Mrinal Gounder, moderated by Dr Neil Love.
S23 Ep 1Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Proceedings from our Year in Review webinar on the management of gynecologic cancers. Featuring perspectives from Drs Michael Birrer and Kathleen Moore, moderated by Dr Neil Love.
S22 Ep 4Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer
Featuring a discussion of the current role of PARP inhibitors in the care of patients with ovarian cancer with Dr Thomas Herzog, moderated by Dr Neil Love.
S22 Ep 3Consensus or Controversy? Current and Future Management of Ovarian Cancer
Featuring a discussion on the management of ovarian cancer with Drs Ursula Matulonis and Debra Richardson, moderated by Dr Neil Love.
S22 Ep 1The Clinical Implications of Key Recent Data Sets in Endometrial Cancer — With Dr Shannon Westin (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)
Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in endometrial cancer. Featuring perspectives from Dr Shannon Westin, moderated by Dr Neil Love.
S22 Ep 2The Clinical Implications of Key Recent Data Sets in Ovarian Cancer — With Dr David O’Malley (Proceedings from a Daylong Multitumor Symposium in Partnership with Florida Cancer Specialists)
Proceedings from a daylong multitumor educational symposium in partnership with the Florida Cancer Specialists, including key clinical presentations and papers in ovarian cancer. Featuring perspectives from Dr David O’Malley, moderated by Dr Neil Love.